- The top hospitals by state, per Forbes
- Dentists could soon play a larger role in vaccine administration: Research
- 8 behavioral health layoffs to know | 2026
- 19 new behavioral health projects to know
- Humana to exit Medicare Advantage plans covering 600,000 members in 2027
- Inside Inova’s 46% release fill rate: Turning open OR time into more cases
- 26 new behavioral health study findings to know
- Why solo dentistry could soon be on the way out
- The survival test for provider-sponsored health plans
- CMS finalizes payment rules for inpatient psychiatric, skilled nursing facilities: 12 things to know
- Feds’ ER records request leaves systems in limbo
- Qilin ransomware racks up 168 healthcare victims
- Inside UVM Health’s affordability-centered response to a $220M revenue hit
- The 5 biggest health system layoffs in 2026
- FTC sues Hims & Hers over health data sharing, billing practices
- Real estate firm acquires newly built ASC in Wisconsin
- California urology group joins PE-backed Unio
- Dental school debt vs. medical school debt: 4 stats
- Children’s Hospital Los Angeles appoints Dr. Andrew Costandi as anesthesiologist-in-chief
- FTC sues Hims & Hers over data privacy, billing practices
- GEICO accuses 2 NYC physician groups of $2M fraud scheme
- MOB deal activity dropped $655M in Q2: 6 things to know
- How this North Carolina surgeon dodged a $2M ASC build-out
- ‘You can’t out-recruit a retention problem’: Inside dentistry’s labor crisis
- The shifting dental payer landscape
- New York City dental practices named in deceptive treatment financing lawsuit
- The ChatGPT, health tech vendor reckoning
- Oregon psychiatric hospital cuts 34 beds, to lay off 45 employees
- Who’s buying up spine practices?
- 15 rising stars in orthopedic surgery
- CMS' proposed 340B reimbursement cut—who wins, and who loses?
- American Gastroenterological Association CEO to retire after 12 years
- Virtual care helps patients improve their gambling disorder symptoms, Birches Health finds
- Texas DSO hit with cyberattack affecting 30,000 individuals
- How 3 Connecticut hospitals responded to rising psychiatric ED demand
- Nuvia Dental Implant Center to open in Texas
- Specialty1 Partners enters joint venture with Ohio periodontal practice
- Federal judge halts mental health grant terminations, again: 7 notes
- Acadia reports $10.9M Q2 profit, down 64% year over year
- CMS ending Medicare Part D subsidy program
- Red Cross Declares Rare National Blood Supply Crisis Amid Summer Shortfall
- Not Just Pregnancy Fatigue: Could It Be Sleep Apnea?
- More Women Drinking During Pregnancy
- HHS launches behavioral health pledge as Optum preps new services
- Wellstar Health System lays off 761 corporate, administrative staff
- Biogen flips '26 guidance from expected decline to sales increase
- Teva’s innovation engine offsets generics slump, leaving one analyst ‘shocked’ by Ajovy’s surge
- Talking To Your Baby? Eye Contact Is Key To Language Development, Experiment Shows
- Boosted by CMS settlement, Incyte expects Opzelura to cross $1B in 2026
- Leapfrog launches expanded ASC public reporting program
- Cyclospora Boosts Fears That Deadlier Foodborne Outbreaks Are Ahead
- DoorDash, GrubHub Delivering Junk Food To 1 In 4 Teens During School Hours
- Hospice’s Bad Reputation Amid Fraud Crisis Will Hurt Patients, Industry Experts Warn
- Trump Has Quietly Throttled an Agency Devoted to the Safety of American Healthcare
- Uninsured but Undaunted, a Surgical Patient Searched the Globe for a Deal
- A look at CVS’ march toward a simpler patient experience
- Humana plans more market exits for 2027, CFO says
- PMCPA sanctions melatonin drugmaker over misleading information
- The high stakes of pediatric dental sedation: Understanding the clinical and legal risks facing pediatric dentists
- AI doctor startup Doctronic acquires Summer Health to move into pediatric care
- Autistic patients less likely to receive on-time cancer screening: Study
- Rare disease foundation partners with Citizen Health to embed AI agent into everyday care
- Community Medical’s CEO on Medicaid cuts: ‘It’s not something that keeps me up at night’
- AI, energy prices will strain hospitals' non-labor spending in 2027: Vizient
- CG Life embraces next-gen era in merger with AI-native agency The Considered+AI
- How 2 FDA citations complicate Hengrui, Elevar’s push for liver cancer combo approval
- American Red Cross declares second-ever national blood supply crisis, urges ‘immediate’ donations
- Fifth Death Reported In NYC Legionnaires' Disease Outbreak
- Universal Health Services tops Q2 expectations, but dials back full-year earnings
- Many Young Adults Aren't Ready To Manage Their Own Healthcare, Poll Finds
- Can A Daily Multivitamin Help You Stay Active As You Age?
- With $5.5B settlement offer, J&J could be on its way to resolving talc litigation
- Prebiotic Soda Health Claims Questioned In New Nutrition Study
- Family-Based Childhood Obesity Program Helps Kids Cut Weight, Become Healthier
- To Afford Aging In Place, Older Adults Turn To 'Golden Girls' Housing
- Breakfast Can Help Teens Make Better Food Choices Throughout Their Day, Study Says
- GSK CEO targets $2.5B in cost savings from mature products, procurement, supply chain
- Newsom Reverses on Long-Sought Paid Leave Benefit for Teachers in California
- Federal Loan Caps Add Barriers — And Likely Debt — for Healthcare Students
- Cyclospora Boosts Fears That Worse Foodborne Outbreaks Are Ahead
- Margin improvements underpin Centene's strategy for 2027 ACA plans, CEO says
- Baxter issues recall of antibiotic IV bags after bits of cardboard flagged in solution
- Havas Lynx revamps New York C-suite 16 months after last shakeup
- LifeBridge Health deploys Prenosis' FDA-authorized AI tool to speed sepsis detection
- Included Health inks agreement to acquire Firefly Health to scale alternative health plans for employers
- Gilead uses humor, relatability in ‘Up to Date’ HIV prevention push
- FDA Panel Backs Two Peptides For Compounding, Rejects One
- Aurenar lands $5.7M seed funding round for non-invasive neuromodulation platform
- Industry survey finds MA enrollees have lower out-of-pocket costs than those in traditional Medicare
- How Accurate Are Photo-Based Calorie Apps? 4 Are Put To The Test
- Procode AI secures $10M series A for AI-powered RCM for surgical billing
- Intermountain Health acquiring interests in 2 Idaho hospitals for $795M
- Sarepta taps AbbVie, Tessera vet Severino to write Duchenne firm's next chapter
- FDA approves Otsuka’s ADHD drug Simtriyo, teeing up its ‘next major CNS launch’
- On 4th try, Outlook scores FDA nod for reformulated version of Roche's Avastin for AMD
- AZ stays on track for $80B revenue goal as cancer meds, rare disease sales help offset Ultomiris miss
- Popular School Cafeteria Meals Need An Update To Meet Healthy Food Standards, Researchers Say
- Ovarian Syndrome Quadruples Heart Disease Risk In Women, Major Study Concludes
- Weed-Killing Chemical, Glyphosate, Linked To Premature Births In Humans, Study Says
- Legend Biotech CEO abruptly steps down without permanent replacement
- 'The Child Is Terrified': Doctors On Front Lines Of Measles Comeback Speak Out
- 'Yo-yo' Weight Loss Linked To Decline In Muscle Mass
- Tracking State Rural Health Transformation Plans
- Trump Administration Demands Hospitals Share Emergency Room Records
- As AI scribe adoption grows, researchers at Suki challenge the industry's quality playbook
- Journalists Assess Risks of Tick Bites, Wildfire Smoke, Rising Health Costs
- Salesforce lands $1.6B Veteran Affairs deal to integrate AI into healthcare workflows
- FDA Advisers Dismiss Safety Warnings, Back Four Peptide Treatments
- Frequent Marijuana Use Linked To Higher Stress Hormone Levels
- Peptide adcomm Day 2: Emideltide voted down in panel's 1st pushback
- Novo escalates Lilly false advertising suit with planned bid to halt comparative ads
- Amgen hands in data package in hopes of FDA hearing for Tavneos defense
- Another setback for Ipsen's Albireo portfolio as Bylvay flunks phase 3 trial
- Flourish Health secures $26M to scale intensive youth mental healthcare
- Back Pain? Try Swimming, Study Says
- Ozempic Cuts Down Calorie Intake For At Least A Year, Even If Hunger Returns, Trial Finds
- Money Problems Might Make Your Brain Old Before Its Time, Study Suggests
- Merck stages expanded access to monthly HIV PrEP pill ahead of approval
- Black MS Patients Dying Younger Than White Ones, Study Finds
- Public Health Improvements Stall Amid Trump's DEI Crackdown
- To Afford Aging in Place, Older Adults Turn to ‘Golden Girls’ Housing
- Gastroenterologists flag clinical remission and its durability as unmet needs in IBD care: survey
- Many U.S. Schools Unprepared To Help Concussed Students Return To The Classroom
- Nearly 1.6 Million Dozen Eggs Pulled From Shelves Over Salmonella Concerns
- Organized Sports Help Enhance Motor Skills In Children With Autism
- People Living Longer, But Spending More Years With Illness And Disability
- Exercise Underwhelms As A Hip Arthritis Treatment, Review Concludes
- Tongue Pacemaker Might Improve Sleep Apnea Patients' Health
- Poll: Costs Are Top Health Care Issue For Midterm Voters, But Fraud Tops GOP List
- Measles Cases Set 35-Year US Record With Months To Go In 2026
- Taylor Farms Faces Cyclospora Outbreak, Recalls And Political Questions
- Headstands and Summervaults: A Statement on Crypto Vaults and Lending Strategies
- GLP-1 Use Surges Among Young People With Obesity
- 1 In 4 Americans Stuck In Jobs For Health Insurance, Survey Finds
- How Does ADHD Affect Athletes' Concussion Risk?
- TV Does Indeed Rot Your Brain, Study Says
- HaloMD's Patrick Velliky explains why No Surprises Act IDR enforcement matters
- The CSO Model Is Endangered. Here’s How Contract Field Organizations Must Evolve to Survive.
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Seeking Public Comment on Seeking Public Capital: Remarks Before the Small Business Capital Formation Advisory Committee
- Remarks to the Small Business Capital Formation Advisory Committee
- Statement on Regulation E-Delivery
- Paper Taper: Statement on Proposed Regulation E-Delivery
- Statement on Proposed Regulation E-Delivery
- Remarks before the American-Hellenic Chamber of Commerce
- Remarks at the Society for Corporate Governance Conference
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
Michigan healthcare freedom community forum
Department of Health and Human Services Secretary Kennedy reconstituted the Interagency Autism Coordinating Committee (I-ACC) in January with 21 new public members. Now beginning their mandate, they have attacted a great deal of criticism from the establishment:
Kennedy's new US autism panel to examine potential causes
By Leah Douglas and Ahmed Aboulenein - March 5, 2026Summary
- New panel includes vaccine skeptics, raising concerns among autism experts
- Panel could explore controversial vaccine links
- Outside experts warn focus on vaccines may divert funds from other autism research
WASHINGTON, March 5 (Reuters) - A U.S. autism advisory board remade by Health Secretary Robert F. Kennedy Jr. to include vaccine skeptics aims to steer federal research spending toward investigating causes of the condition, as well as other issues like co-occurring medical disorders, according to some new panel members.
Kennedy, a longtime anti-vaccine activist who has suggested the inoculations cause autism, contrary to scientific evidence, reset the Interagency Autism Coordinating Committee in January with 21 new public members. More than a third of the new committee members have also promoted the debunked link between vaccines and autism.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
Some autism experts, including former committee members, have said the new members could undermine federal autism research. This week, some former members created their own alternative advisory board, the latest in a series of similar efforts by public health experts concerned about Kennedy's overhaul of federal vaccine policy and what they see as misinformation coming from agencies he oversees.No rigorous studies have found links between autism and vaccines or medications. Autism experts attribute rising rates of the condition largely to more inclusive diagnosis criteria.
The committee, due to first meet on March 19, will provide non-binding guidance to Kennedy on federal autism research priorities, including recommendations on allocating hundreds of millions of dollars in research spending.
Kennedy has promised President Donald Trump he will identify the cause of autism, which most researchers suggest is linked in part to genetics and exposure in utero to pollutants or harmful contaminants. Many of Kennedy's supporters in the Make America Healthy Again movement - some of whom were named to the committee - also believe vaccines can cause autism and advocate for fewer childhood vaccinations.
Committee chair Sylvia Fogel, a psychiatrist and instructor at Harvard Medical School, told Reuters the committee will address gaps in autism research like causal triggers in an effort to better serve people with profound autism and their families.
"Autism is not monolithic. Federal strategy should reflect that complexity rather than flatten it," Fogel said.
Department of Health and Human Services spokesman Andrew Nixon said the new committee is meant to unite a range of voices and that "expanding perspectives on the panel does not change the fact that federal research is grounded in rigorous science."
SOME MEMBERS LINK VACCINES AND AUTISM
Until January's overhaul, major autism groups like the Simons Foundation and Autism Speaks, and researchers from universities including Johns Hopkins and Tufts accounted for most of the committee's 21 members from the public.
That panel recommended further research into co-occurring physical and behavioral health conditions, like epilepsy, gastrointestinal issues and anxiety disorders, according to a draft 2024 report.
David Sitcovsky, vice president of advocacy at Autism Speaks, said in a statement that broader representation would strengthen the committee, but that its impact would depend on retaining a grounding in science.
The new panel contains more activists, just three autistic self-advocates - the minimum required by law - down from seven, and few representatives from research universities. At least eight have tied vaccination to autism or are connected to organizations that support those claims, including several who say their children developed autism after being vaccinated, according to a Reuters review of their public statements and affiliations.
Panel member Ginger Taylor, who created a website called "How Do Vaccines Cause Autism?", wrote in a Substack post that her top priority for the committee is investigating the link between vaccines and autism.
John Gilmore, a new panel member and co-founder of the Autism Action Network who says his 26-year-old son developed autism after being vaccinated, said he wants to steer more research toward rising autism rates.
"A lot of the voices that are on the (committee) now have been deliberately excluded for 20-odd years," he said.
Several, including Gilmore and Fogel, appeared on panels at a September autism event hosted by the MAHA Institute, whose president, Mark Gorton, is an anti-vaccine activist and was a significant funder of Kennedy's 2024 presidential campaign.
Asked how some members' views on vaccines will affect the committee's work, Fogel said studies of the measles-mumps-rubella vaccine and thimerosal-containing vaccines have not shown a causal link to autism.
"That body of available evidence is substantial and must be acknowledged," Fogel said.
Still, research should examine how various exposures, including immune or inflammatory stress, might affect autism outcomes, she said.
EXPERT CONCERNS
On Tuesday, a dozen autism advocates, researchers and several former committee members formed the Independent Autism Coordination Committee to create its own strategic plan for autism research.
Alison Singer, president of the Autism Science Foundation and a prior government committee member, said investing federal dollars into researching a link between vaccines and autism, which most experts consider settled science, would cut into funding for other research opportunities, like autism's heritability or link to environmental exposures.
"There’s not a bottomless pit of money at the NIH that can be used to fund research," Singer said. "If we devote our very limited resources towards reinvestigating vaccines, we won’t have money to look at actual potential causes of autism."
More on the self appointed Independent Autism Coordinating Committee (I-ACC), with a deceitful name and acronym deliberately chosen to confuse the public into thinking that it is the official Interagency Autism Coordinating Committee (I-ACC):
Autism researchers rebuke Kennedy, form independent advisory group
The group wants to be a bulwark against potential misinformation from federal health agencies
By O. Rose Broderick - March 3, 2026A group of autism researchers and advocates announced Tuesday the formation of an independent advisory body that will develop a scientific agenda for the autism community. They hope to act as a bulwark against a federal committee bearing a similar name and its new members who believe that childhood vaccines can cause autism, despite the lack of evidence for such a link.
The Independent Autism Coordinating Committee (I-ACC) will hold its first meeting on March 19 — the same day that the newly-reformed federal body, the Interagency Autism Coordinating Committee (IACC), will meet for its first publicly-announced meeting, as first reported by the Washington Post.
The independent body’s leaders see their group and future actions as a direct rebuke of health secretary Robert F. Kennedy Jr. and his decision to refashion the federal body with members who align with his views on autism and vaccines, instead of preeminent researchers and autistic self-advocates.
“We don’t believe that the new federal IACC is going to pursue the kinds of areas and priorities that the mainstream scientific community feels are important at this point,” said Helen Tager-Flusberg, a member of the new group and director of the Center for Autism Research Excellence at Boston University.
The independent group includes many former members of the federal body, such as Joshua Gordon, former National Institute of Mental Health director, and Alison Singer, president of the Autism Science Foundation. The 12 members are mostly researchers, a contrast with the federal body, whose members mostly focus on advocacy.
Tager-Flusberg says the group will not rehash every matter the federal body considers, but they will primarily determine which topics within autism research deserve the most attention, with an eye on informing the decisions of non-governmental funders. The group will continue to meet whenever the federal body meets in an attempt to halt any misinformation that emerges from the meeting. If, for example, IACC plans to discuss vaccines and autism, the researchers will host a meeting and discuss the existing evidence on the topic on the same day.
When asked whether the similar names, meeting dates, and purported goals could sow confusion in the autism community about who to trust, she responded, “Are you going to pay attention to the group that contains not a single reputable scientist, or anyone experienced with conducting research? Or are you going to look at a group of people, which includes the people who have all the credentials that you would expect from the membership of the IACC?”
The Department of Health and Human Services has no plans to change the federal body’s proceedings in response to their independent counterpart. “The federal IACC will continue to fulfill President Trump’s directive to bring autism research to the 21st century and support breakthroughs in autism diagnosis, treatment, and prevention,” said Andrew Nixon, an HHS spokesperson.
This is not the first group of researchers and advocates who have formed their own advisory group as a bid to push back against misinformation from the federal government. The Vaccine Integrity Project launched last year as a means for assessing and disseminating the best available evidence on vaccines.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















